Risperdal, also known by the name of its active ingredient, risperidone, is an antipsychotic medication approved to treat symptoms of schizophrenia, bipolar disorder, and autism in some individuals.
Unfortunately, the doctors have also prescribed Risperdal for unapproved uses, and some users have experienced serious and unexpected side effects.
In addition to other serious side effects, the use of Risperdal has been linked to a condition called gynecomastia, or the enlargement of male breast tissue. Gynecomastia has been especially devastating for young boys who have taken the drug.
And also you can find the latest new on lawsuit for Risperdal and information from the authority on drug interactions and side effects, Drug Dangers.
The U.S. Food & Drug Administration (FDA) has issued many warnings related to the drug, emphasizing the dangers it may pose to users.
Dangers of Side Effects of Risperdal
Although it received approval for use in treating schizophrenia (including adolescent schizophrenia), bipolar disorder, and irritability in people with autism, Risperdal may cause a variety of unintended health problems beyond the typically mild side-effects. Some of the problems related to Risperdal use include:
- Diabetes, high blood sugar (hyperglycemia)
- Sexual dysfunction
- Pituitary tumors
- Tardive dyskinesia (involuntary movement)
- Neuroleptic Malignant Syndrome (NMS)
- Heart attacks
- Suicide or thoughts of suicide
- Increased risk of death among elderly people with dementia
- Bone loss (demineralization)
These side effects range in severity from mild to potentially life-threatening, and as a result, many individuals who have suffered after Risperdal use are now taking legal action against Johnson & Johnson to pursue compensation for their resulting losses.
Risperdal is an antidepressant prescribed by health practitioners for bipolar and schizophrenia disorders.
The downside of the drug is that it may cause an increased level of prolactin, which can result in breast enlargement among male patients.
The FDA released advisory related to the risk of death in elderly patients, and uncontrollable abnormal movements around the shoulder, face, and limbs of patients.